Sigma Planning Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sigma Planning Corp’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$484K	Buy	+2,009	New	+$440K	0.01%	925
2022 Q1	–	Sell	-1,637	Closed	-$209K	–	1439
2021 Q4	$209K	Buy	+1,637	New	+$215K	0.01%	1263
2021 Q3	–	Sell	-1,478	Closed	-$263K	–	1440
2021 Q2	$263K	Buy	+1,478	New	+$256K	0.01%	1154

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Sigma Planning Corp's JAZZ Position: Q2 2026 in Review

Sigma Planning Corp opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2,009 shares worth $484K. The stake represents 0.01% of the portfolio and ranks #925 among its holdings. This is a return to the name: Sigma Planning Corp previously reported a position in JAZZ as recently as Q4 2021.

Sigma Planning Corp first reported a position in JAZZ in Q2 2021 and has held it in 3 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Sigma Planning Corp held 2,009 shares of Jazz Pharmaceuticals worth $484K as of Q2 2026.
Jazz Pharmaceuticals was a new Sigma Planning Corp position in Q2 2026.
Jazz Pharmaceuticals made up 0.01% of Sigma Planning Corp's portfolio in Q2 2026, its #925 holding.
Sigma Planning Corp first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.